Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where enhanced metabolic stability and bioavailability are desired. Its structure supports the creation of compounds with improved binding affinity and selectivity, especially in central nervous system agents and anti-inflammatory drugs. Commonly employed in research settings for designing novel drug candidates due to the combined influence of fluorine and trifluoromethyl groups on lipophilicity and electronic effects.